A Trial of the Safety of Escalating Doses of PRO131921 in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Chronic Lymphocytic Leukemia
Related studies linked through entity extraction aliases.
Kinetic Biomarker for Chronic Lymphocytic Leukemia Prognosis
- Status
- COMPLETED
- Phase
- N/A
A Study of ABT-263 in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Lenalidomide in Acute Leukemias and Chronic Lymphocytic Leukemia.
- Status
- COMPLETED
- Phase
- PHASE1
FCR and Bevacizumab in the Treatment of Relapsed Chronic Lymphocytic Leukemia (CLL)
- Status
- COMPLETED
- Phase
- PHASE2
Study of Intravenously Administered SNS-032 in Patients With Advanced B-lymphoid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Reduced Intensity Stem Cell Transplantation for Chronic Lymphocytic Leukemia Followed by Vaccination
- Status
- COMPLETED
- Phase
- PHASE1
Dasatinib in Relapsed Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine Generation
- Status
- COMPLETED
- Phase
- PHASE1
A Dose Escalation Study of Lenalidomide in Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Combination Chemotherapy With or Without G-CSF in Treating Patients With Relapsed Chronic Lymphocytic Leukemia
- Status
- TERMINATED
- Phase
- PHASE3
5-Azacytidine (Azacytidine; Vidaza) in Chronic Lymphocytic Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
Lumiliximab With Fludarabine, Cyclophosphamide, and Rituximab (FCR) Versus FCR Alone in Subjects With Relapsed Chronic Lymphocytic Leukemia (CLL)
- Status
- TERMINATED
- Phase
- PHASE2
FCR Plus Sargramostim (GM-CSF) as Frontline Therapy for Symptomatic Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Methods to Enhance the Safety and Effectiveness of Stem Cell Transplants
- Status
- COMPLETED
- Phase
- PHASE2
Allogeneic Stem Cell Transplantation in Chronic Lymphocytic Leukemia
- Status
- UNKNOWN
- Phase
- PHASE2
Weekly Subcutaneous Alemtuzumab and Rituximab for Relapsed CLL
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1, Dose-Escalation, Pharmacodynamic Study of IV CNF1010 in ZAP-70 Positive CLL
- Status
- TERMINATED
- Phase
- PHASE1
Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia (CLL) That Did Not Respond to Fludarabine, CLL With Autoimmune Haemolytic Anemia (AIHA) or Richter's Transformation (RT)
- Status
- COMPLETED
- Phase
- PHASE2
Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases
- Status
- COMPLETED
- Phase
- PHASE2